Pagsiat, Anecito T.

HRN: 09-22-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CEFAZOLIN 1GM (VIAL)
02/18/2026
02/25/2026
IV
1g
Q8
Lacerated Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: